Skip to main content

sec filings

Insider trades

Open-market buys and sales that company insiders report to the SEC on .

Side
Planned sales
Role
PBYI

Updated 10/6/2026, 8:11 AM ET.

PBYI

PUMA BIOTECHNOLOGY, INC.

Sale$45,500

WILSON TROY EDWARD

Director

5,000 shat $9.10Filed Sep 16, 9:13 PM ET
Filing
PBYI

PUMA BIOTECHNOLOGY, INC.

Sale$566,994

Cesano Alessandra

Director

62,150 shat $9.12Filed Sep 16, 9:06 PM ET
Filing
PBYI

PUMA BIOTECHNOLOGY, INC.

Sale$364,051

AUERBACH ALAN H

President and CEO, Director, 10% owner

44,058 shat $8.26Filed Jul 8, 8:21 PM ET
Filing
PBYI

PUMA BIOTECHNOLOGY, INC.

Sale$69,905

HUNT DOUGLAS M

See Remarks

8,460 shat $8.26Filed Jul 8, 8:19 PM ET
Filing
PBYI

PUMA BIOTECHNOLOGY, INC.

Sale$77,557

NOUGUES MAXIMO F

Chief Financial Officer

9,386 shat $8.26Filed Jul 8, 8:18 PM ET
Filing

Read from public SEC filings. Not financial advice.